| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Frankenius Equity Ab last filed a Form 4 in July 2025, as 10% Owner at TLSI. Frankenius Equity Ab's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 6,989,748 shares of TLSI. Net of sales, the TLSI filings show accumulation of 62,972 shares.
Frankenius Equity Ab has 3 Form 4 filings on record from December 2024 to July 2025, all as 10% Owner at TriSalus Life Sciences (TLSI), 2024–2025.
The 3 reported transactions were 1 conversion, 1 other transaction and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $250K and no sales.
The only open-market purchase was 62,972 shares of TLSI at an average $3.97 on December 17, 2024, about $250K. Twelve months later TLSI was up 92%.
Shares as reported in the last Form 4 for each company; the most recent is from July 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | TLSI Trisalus Life Sciences, Inc. | 10% Owner | Buy | 62,972 | $3.97 | $249,998.84 | +1.0% | +35.2% | +91.6% |